At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Feb 26, 2026 at 19:00 ET
A recent insider trading cluster at United Therapeutics includes two open-market share sales totaling $127K and two derivative exercises worth $1.5M. The CEO and another executive exercised options but did not sell the underlying shares, while two other insiders sold small amounts in the open market.
- CEO Martine Rothblatt exercised options for 9,500 shares at $146.03 (value: $1.39M), a non-cash transaction.
- Christopher Causey exercised options for 1,000 shares at $119.76 (value: $119,760), also non-cash.
- Malcolm Jan sold 50 shares for $25,460 and Judy Olian sold 200 shares for $101,910, both open-market sales.
- Total open-market selling: $127,370 (<0.001% of $22.5B market cap).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access